查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
到 2030 年基因編輯市場預測：按產品、技術、應用、最終用戶和地區進行的全球分析
市場調查報告書
商品編碼
1383399

到 2030 年基因編輯市場預測：按產品、技術、應用、最終用戶和地區進行的全球分析

Gene Editing Market Forecasts to 2030 - Global Analysis By Product, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球基因編輯市場規模為 74.5 億美元，預計預測期內年複合成長率為 17.5%，到 2030 年將達到 230.5 億美元。

一組被稱為「基因編輯」的技術允許研究人員修改生物體的 DNA。這些技術使得改變、添加或去除基因組內特定位置的遺傳物質成為可能。基因組編輯對於人類疾病預防和治療來說是一個有吸引力的領域。更複雜的疾病，如癌症、心臟病、精神疾病和愛滋病毒感染疾病，也可以使用這項技術來治療或預防。

根據美國國立衛生研究院 (NIH) 的數據，大約有 7,000 種罕見疾病影響著 2500 至 3000 萬美國人。

基因組學的應用日益廣泛

基因組學擴大用於測試食品品質和安全。基因組編輯技術對於發現新藥物以及識別和治療人類遺傳疾病至關重要。 NGS、DNA 分析和分析以及動植物性因工程都採用基因組編輯。在評估魚類族群時，NGS 可用於 DNA 條碼來識別魚卵和幼蟲，或全面表徵魚類群落。因此，在預測期內，隨著基因組分析應用領域的擴大，對基因組編輯技術的需求可能會增加。

高成本

基因編輯療法的研究和開發成本高且耗時。公司和組織可能很難籌集徹底的初步測試和臨床試驗所需的資金。基因編輯藥物的開發很大程度上依賴臨床試驗，而臨床試驗的費用相當昂貴。這些試驗通常涉及多個階段和大量人員，需要證明基因編輯療法的安全性和有效性。因此，高成本是市場拓展的主要障礙。

遺傳病患病率上升

推動基因編輯市場的主要因素之一是遺傳疾病盛行率的上升。這一趨勢的本質特徵是被診斷出患有罕見疾病和各種遺傳性疾病的人數增加。 CRISPR-Cas9等基因編輯技術能夠識別和糾正導致這些疾病的潛在遺傳異常，因此患者終於可以看到希望。這些因素正在推動市場需求。

CRISPR 的脫靶效應

基因編輯技術的一個顯著限制是CRISPR技術的脫靶效應。儘管 CRISPR-Cas9 可以以令人難以置信的精確度靶向特定基因，但它也可能導致預期目標以外的位置發生意外修改。由於這種脫靶活性，CRISPR技術的應用可能會帶來風險和困難。這些因素都阻礙了市場的擴張。

COVID-19 的影響

這場大流行使基因編輯產業受益，因為社交距離規範和醫院床位短缺迫使家庭患者照護系統充分適應。 COVID-19大流行徹底改變了我們的生活。它也進一步加速了科學界對創造力和協作的承諾。隨著疫情在世界各地蔓延，科學家正忙於開發治療方法、疫苗接種和診斷方法。科學家們正在轉向高通量實驗室自動化、人工智慧和機器學習來應對導致 COVID-19 的新型冠狀病毒 SARS-CoV-2。 SARS-CoV-2 對於隔離感染患者並觀察適當的醫療反應是必要的。因此，基因編輯市場受益於 COVID-19 的爆發。

試劑和消耗品部分預計將在預測期內成為最大的部分

試劑和消耗品部分估計佔最大佔有率。試劑和消耗品包括各種物品，例如箔片密封件、玻片支架、板、晶片、管條、文庫製備、精製和目標富集套件。由於基因組學在各行業的應用不斷成長，預計消耗品市場將會成長。文庫製備技術的進步也使得 NGS 在磊晶和轉錄組學中的應用成為可能。這些試劑盒用於定序應用，例如標靶定序和全基因組定序。

簇狀規則間隔的短回文重複片段預計在預測期內具有最高的年複合成長率

預計聚集的等距短回文重複片段將在預測期內實現良好的成長。作為傳統基因修飾方法的替代方法，CRISPR 成簇的規則間隔截斷回文重複序列已成為基因編輯的重要工具。 Cas9 酶是 CRISPR 與傳統 DNA 編輯的不同之處。 CRISPR 透過去除受損或不必要的 DNA 序列來重新排列基因，使剩餘的 DNA 呈現新的配置。

佔比最高的地區

在估計期間，北美佔據了最大的市場佔有率。基因編輯最重要的區域市場是北美。美國是該地區的主要收益來源。在美國，創業投資、政府機構和私人公司正在基因編輯領域進行大量資金和投資。這筆資金籌措加速了基因編輯技術的研究、開發和商業化。治療性介入的發展和基因編輯操作的擴展是由於資金籌措的提供而成為可能的。

複合年複合成長率最高的地區：

預計亞太地區在預測期內將出現盈利成長。這是由於技術突破的增加、新興地區生物技術產業的崛起以及癌症和其他遺傳異常盛行率的上升而推動的。 CRISPR技術創新在日本仍在顯著成長。同時，新興的 CRISPR 研究預計將推動印度市場的成長。此外，印度研究人員也開發了廣泛使用的 CRISPR-Cas9 基因編輯方法的不同變異。這種變異可以提高基因編輯的精確度，而不會導致意外的 DNA 變化。因此，這些變數預計將影響未來年度的亞太基因編輯市場。

提供免費客製化

本報告的所有客戶都將收到以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與企業的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計/預測/年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

介紹

促進因素

抑制因素

機會

威脅

產品分析

技術分析

應用分析

最終用戶分析

新興市場

新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球基因編輯市場：依產品

  • 介紹
  • 軟體及系統
  • 服務
  • 試劑/消耗品

第6章 全球基因編輯市場：依技術分類

  • 介紹
  • 轉錄活化劑樣效應核酸酶
  • 反義
  • 成簇規則間隔短回文重複序列 (CRISPR)
  • 鋅指核酸酶 (ZFN)
  • 其他技術

第7章 全球基因編輯市場：依應用分類

  • 介紹
  • 基因工程
  • 細胞株工程
  • 藥物研發發現與開發
  • 其他用途

第8章 全球基因編輯市場：依最終用戶分類

  • 介紹
  • 學術研究所
  • 製藥和生物技術公司
  • 其他最終用戶

第9章 全球基因編輯市場：按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 中東和非洲其他地區

第10章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章公司簡介

  • Sangamo Therapeutics, Inc.
  • Beam Therapeutics
  • Integrated DNA Technologies, Inc.
  • Thermo Fisher Scientific
  • Horizon Discovery Ltd.
  • Precision Biosciences
  • CRISPR Therapeutics
  • GeneScript
  • Agilent Technologies
  • Intellia Therapeutics, Inc.
  • Caribou Biosciences, Inc.
  • Lonza
  • Perkinelmer
  • Editas Medicine
  • Tecan Life Sciences
  • Amsbio
  • Creative Biogene
Product Code: SMRC24249

According to Stratistics MRC, the Global Gene Editing Market is accounted for $7.45 billion in 2023 and is expected to reach $23.05 billion by 2030 growing at a CAGR of 17.5% during the forecast period. A group of technologies known as "gene editing" enables researchers to modify an organism's DNA. These technologies make it possible to change, add, or remove genetic material at particular locations within the genome. Genome editing is a fascinating field for both illness prevention and treatment in humans. More complicated conditions like cancer, heart disease, mental illness, and HIV infection may also be treated and prevented by using it.

According to the National Institutes of Health (NIH), there are approximately 7,000 rare diseases affecting between 25 and 30 million Americans.

Market Dynamics:

Driver:

Rising applications of genomics

Genomics is increasingly being used in food quality and safety testing. Technologies for editing genomes are essential for both finding new drugs and identifying and treating genetic diseases in humans. NGS, DNA analysis and profiling, and genetic engineering of plants and animals all employ genome editing. When evaluating fish populations, NGS can be utilized for DNA barcoding to identify fish eggs and larvae as well as to fully characterize fish communities. Therefore, during the projection period, there will likely be a rise in demand for genome editing technologies due to the expanding application areas of genomics.

Restraint:

High cost

Gene editing therapy research and development can be costly and time-consuming. It could be difficult for businesses and organizations to get the financing needed for in-depth pre- and clinical testing. The development of gene editing medicine heavily relies on clinical studies, which are quite expensive. These trials, which usually involve several phases and a large number of people, are required to show the safety and effectiveness of gene editing therapy. Therefore, high costs are a significant barrier to market expansion.

Opportunity:

Rising prevalence of genetic illnesses

One major factor fueling the gene editing market is the increase in the prevalence of genetic illnesses. An increase in the number of people receiving diagnoses for uncommon diseases and different genetic disorders essentially characterizes this trend. Patients may finally have hope due to gene editing technologies like CRISPR-Cas9, which have the ability to identify and fix the underlying genetic abnormalities causing these illnesses. These factors propel market demand.

Threat:

Off-target impacts of CRISPR

A significant constraint of gene editing technology is the off-target impacts of CRISPR technology. Although CRISPR-Cas9 can target certain genes with astonishing precision, it can also cause unintentional alterations at places other than the intended target. The application of CRISPR technology may present risks and difficulties as a result of this off-target activity. These factors hinder market expansion.

COVID-19 Impact

The industry for gene editing benefited from the pandemic because social distancing norms and a shortage of hospital beds forced home-based patient care systems to adapt to the fullest. The COVID-19 pandemic has changed our lives. It has also intensified the already swift inclinations toward creation and cooperation among the scientific community. With the pandemic spreading across the globe, scientists are working feverishly to develop treatments, vaccinations, and diagnoses. To tackle SARS-CoV-2, the new coronavirus that causes COVID-19, scientists are looking into high-throughput experimental automation, artificial intelligence, and machine learning. The SARS-CoV-2 is necessary for isolating infected patients and observing appropriate medical responses. Thus, the market for gene editing benefited from the COVID-19 epidemic.

The reagents & consumables segment is expected to be the largest during the forecast period

The reagents & consumables segment is estimated to hold the largest share. Reagents and consumables encompass a wide range of items, including foil seals, slide holders, plates, chips, tube strips, library preparation, purification, and target enrichment kits. The market for consumables is predicted to rise as a result of genomics' expanding applicability in a variety of industries. Utilizing NGS in epigenetic and transcriptomics has also been made possible by developments in library preparation technology. Applications for sequencing, including targeted and whole-genome sequencing, employ these kits.

The clustered regularly interspaced short palindromic repeats segment is expected to have the highest CAGR during the forecast period

The clustered regularly interspaced short palindromic repeats segment is anticipated to have lucrative growth during the forecast period. As an alternative to conventional genetic alteration methods, CRISPR-Clustered Regularly Interspaced Short Palindromic Repeats have become an essential tool for gene editing. The Cas9 enzymes set CRISPR apart from previous types of DNA editing. By removing damaged or undesirable DNA sequences, CRISPR reorganizes genes so that the remaining DNA can take on new configurations.

Region with largest share:

North America commanded the largest market share during the extrapolated period. The most significant regional market for gene editing is North America. The US has become this region's main source of revenue. In the US, venture capitalists, governmental organizations, and private companies have made large financial and investment contributions in the gene editing field. Research and development, as well as the commercialization of gene editing technologies, have been accelerated by this financing. The development of therapeutic interventions and the expansion of gene editing businesses have been made possible by the availability of funding.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period. This is due to increasing technological breakthroughs, a thriving biotechnology industry in emerging regions, and the rising prevalence of cancer and other genetic abnormalities. Innovation in CRISPR technology is still growing significantly in Japan. On the other hand, new CRISPR research is anticipated to propel market growth in India. Additionally, researchers in the nation developed a distinct variation of the widely used CRISPR-Cas9 gene-editing method. The variant may increase the accuracy of gene editing without causing unintended DNA changes. Therefore, in the upcoming years, it is anticipated that these variables will have an effect on the Asia-Pacific gene editing market.

Key players in the market

Some of the key players in the Gene Editing Market include: Sangamo Therapeutics, Inc., Beam Therapeutics, Integrated DNA Technologies, Inc., Thermo Fisher Scientific, Horizon Discovery Ltd., Precision Biosciences, CRISPR Therapeutics, GeneScript, Agilent Technologies, Intellia Therapeutics, Inc., Caribou Biosciences, Inc., Lonza, Perkinelmer, Editas, edicine, Tecan Life Sciences, Amsbio and Creative Biogene.

Key Developments:

In November 2022, Thermo Fisher Scientific (US) announced the launch of Gibco CTS AAV-MAX Helper-Free AAV Production System, an all-in-one solution suitable for commercial and clinical applications associated with AAV-based gene therapies.

In June 2022, Lonza (Switzerland) and Adva entered into a license agreement that will allow Adva to develop innovative solutions for the cell and gene therapies industry.

In February 2023, Gen Script (China) announced the expansion of its Singapore facility to provide a premium gene synthesis service. This marks a significant expansion of the company's advanced gene-synthesis capability and enables Gen Script to provide the service levels required for novel vaccine and therapeutic development in life sciences.

Products Covered:

  • Software & Systems
  • Services
  • Reagents & Consumables

Technologies Covered:

  • Transcription Activator-Like Effector Nuclease
  • Antisense
  • Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
  • Zinc Finger Nuclease (ZFN)
  • Other Technologies

Applications Covered:

  • Genetic Engineering
  • Cell Line Engineering
  • Drug Discovery & Development
  • Other Applications

End Users Covered:

  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction

3.2 Drivers

3.3 Restraints

3.4 Opportunities

3.5 Threats

3.6 Product Analysis

3.7 Technology Analysis

3.8 Application Analysis

3.9 End User Analysis

3.10 Emerging Markets

3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Gene Editing Market, By Product

  • 5.1 Introduction
  • 5.2 Software & Systems
  • 5.3 Services
  • 5.4 Reagents & Consumables

6 Global Gene Editing Market, By Technology

  • 6.1 Introduction
  • 6.2 Transcription Activator-Like Effector Nuclease
  • 6.3 Antisense
  • 6.4 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
  • 6.5 Zinc Finger Nuclease (ZFN)
  • 6.6 Other Technologies

7 Global Gene Editing Market, By Application

  • 7.1 Introduction
  • 7.2 Genetic Engineering
  • 7.3 Cell Line Engineering
  • 7.4 Drug Discovery & Development
  • 7.5 Other Applications

8 Global Gene Editing Market, By End User

  • 8.1 Introduction
  • 8.2 Academic and Research Institutes
  • 8.3 Pharmaceutical and Biotechnology Companies
  • 8.4 Other End Users

9 Global Gene Editing Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Sangamo Therapeutics, Inc.
  • 11.2 Beam Therapeutics
  • 11.3 Integrated DNA Technologies, Inc.
  • 11.4 Thermo Fisher Scientific
  • 11.5 Horizon Discovery Ltd.
  • 11.6 Precision Biosciences
  • 11.7 CRISPR Therapeutics
  • 11.8 GeneScript
  • 11.9 Agilent Technologies
  • 11.10 Intellia Therapeutics, Inc.
  • 11.11 Caribou Biosciences, Inc.
  • 11.12 Lonza
  • 11.13 Perkinelmer
  • 11.14 Editas Medicine
  • 11.15 Tecan Life Sciences
  • 11.16 Amsbio
  • 11.17 Creative Biogene

List of Tables

  • Table 1 Global Gene Editing Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Gene Editing Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Gene Editing Market Outlook, By Software & Systems (2021-2030) ($MN)
  • Table 4 Global Gene Editing Market Outlook, By Services (2021-2030) ($MN)
  • Table 5 Global Gene Editing Market Outlook, By Reagents & Consumables (2021-2030) ($MN)
  • Table 6 Global Gene Editing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 7 Global Gene Editing Market Outlook, By Transcription Activator-Like Effector Nuclease (2021-2030) ($MN)
  • Table 8 Global Gene Editing Market Outlook, By Antisense (2021-2030) ($MN)
  • Table 9 Global Gene Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) (2021-2030) ($MN)
  • Table 10 Global Gene Editing Market Outlook, By Zinc Finger Nuclease (ZFN) (2021-2030) ($MN)
  • Table 11 Global Gene Editing Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 12 Global Gene Editing Market Outlook, By Application (2021-2030) ($MN)
  • Table 13 Global Gene Editing Market Outlook, By Genetic Engineering (2021-2030) ($MN)
  • Table 14 Global Gene Editing Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
  • Table 15 Global Gene Editing Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
  • Table 16 Global Gene Editing Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 17 Global Gene Editing Market Outlook, By End User (2021-2030) ($MN)
  • Table 18 Global Gene Editing Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 19 Global Gene Editing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 20 Global Gene Editing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 21 North America Gene Editing Market Outlook, By Country (2021-2030) ($MN)
  • Table 22 North America Gene Editing Market Outlook, By Product (2021-2030) ($MN)
  • Table 23 North America Gene Editing Market Outlook, By Software & Systems (2021-2030) ($MN)
  • Table 24 North America Gene Editing Market Outlook, By Services (2021-2030) ($MN)
  • Table 25 North America Gene Editing Market Outlook, By Reagents & Consumables (2021-2030) ($MN)
  • Table 26 North America Gene Editing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 27 North America Gene Editing Market Outlook, By Transcription Activator-Like Effector Nuclease (2021-2030) ($MN)
  • Table 28 North America Gene Editing Market Outlook, By Antisense (2021-2030) ($MN)
  • Table 29 North America Gene Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) (2021-2030) ($MN)
  • Table 30 North America Gene Editing Market Outlook, By Zinc Finger Nuclease (ZFN) (2021-2030) ($MN)
  • Table 31 North America Gene Editing Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 32 North America Gene Editing Market Outlook, By Application (2021-2030) ($MN)
  • Table 33 North America Gene Editing Market Outlook, By Genetic Engineering (2021-2030) ($MN)
  • Table 34 North America Gene Editing Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
  • Table 35 North America Gene Editing Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
  • Table 36 North America Gene Editing Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 37 North America Gene Editing Market Outlook, By End User (2021-2030) ($MN)
  • Table 38 North America Gene Editing Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 39 North America Gene Editing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 40 North America Gene Editing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 41 Europe Gene Editing Market Outlook, By Country (2021-2030) ($MN)
  • Table 42 Europe Gene Editing Market Outlook, By Product (2021-2030) ($MN)
  • Table 43 Europe Gene Editing Market Outlook, By Software & Systems (2021-2030) ($MN)
  • Table 44 Europe Gene Editing Market Outlook, By Services (2021-2030) ($MN)
  • Table 45 Europe Gene Editing Market Outlook, By Reagents & Consumables (2021-2030) ($MN)
  • Table 46 Europe Gene Editing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 47 Europe Gene Editing Market Outlook, By Transcription Activator-Like Effector Nuclease (2021-2030) ($MN)
  • Table 48 Europe Gene Editing Market Outlook, By Antisense (2021-2030) ($MN)
  • Table 49 Europe Gene Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) (2021-2030) ($MN)
  • Table 50 Europe Gene Editing Market Outlook, By Zinc Finger Nuclease (ZFN) (2021-2030) ($MN)
  • Table 51 Europe Gene Editing Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 52 Europe Gene Editing Market Outlook, By Application (2021-2030) ($MN)
  • Table 53 Europe Gene Editing Market Outlook, By Genetic Engineering (2021-2030) ($MN)
  • Table 54 Europe Gene Editing Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
  • Table 55 Europe Gene Editing Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
  • Table 56 Europe Gene Editing Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 57 Europe Gene Editing Market Outlook, By End User (2021-2030) ($MN)
  • Table 58 Europe Gene Editing Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 59 Europe Gene Editing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 60 Europe Gene Editing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 61 Asia Pacific Gene Editing Market Outlook, By Country (2021-2030) ($MN)
  • Table 62 Asia Pacific Gene Editing Market Outlook, By Product (2021-2030) ($MN)
  • Table 63 Asia Pacific Gene Editing Market Outlook, By Software & Systems (2021-2030) ($MN)
  • Table 64 Asia Pacific Gene Editing Market Outlook, By Services (2021-2030) ($MN)
  • Table 65 Asia Pacific Gene Editing Market Outlook, By Reagents & Consumables (2021-2030) ($MN)
  • Table 66 Asia Pacific Gene Editing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 67 Asia Pacific Gene Editing Market Outlook, By Transcription Activator-Like Effector Nuclease (2021-2030) ($MN)
  • Table 68 Asia Pacific Gene Editing Market Outlook, By Antisense (2021-2030) ($MN)
  • Table 69 Asia Pacific Gene Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) (2021-2030) ($MN)
  • Table 70 Asia Pacific Gene Editing Market Outlook, By Zinc Finger Nuclease (ZFN) (2021-2030) ($MN)
  • Table 71 Asia Pacific Gene Editing Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 72 Asia Pacific Gene Editing Market Outlook, By Application (2021-2030) ($MN)
  • Table 73 Asia Pacific Gene Editing Market Outlook, By Genetic Engineering (2021-2030) ($MN)
  • Table 74 Asia Pacific Gene Editing Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
  • Table 75 Asia Pacific Gene Editing Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
  • Table 76 Asia Pacific Gene Editing Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 77 Asia Pacific Gene Editing Market Outlook, By End User (2021-2030) ($MN)
  • Table 78 Asia Pacific Gene Editing Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 79 Asia Pacific Gene Editing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 80 Asia Pacific Gene Editing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 81 South America Gene Editing Market Outlook, By Country (2021-2030) ($MN)
  • Table 82 South America Gene Editing Market Outlook, By Product (2021-2030) ($MN)
  • Table 83 South America Gene Editing Market Outlook, By Software & Systems (2021-2030) ($MN)
  • Table 84 South America Gene Editing Market Outlook, By Services (2021-2030) ($MN)
  • Table 85 South America Gene Editing Market Outlook, By Reagents & Consumables (2021-2030) ($MN)
  • Table 86 South America Gene Editing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 87 South America Gene Editing Market Outlook, By Transcription Activator-Like Effector Nuclease (2021-2030) ($MN)
  • Table 88 South America Gene Editing Market Outlook, By Antisense (2021-2030) ($MN)
  • Table 89 South America Gene Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) (2021-2030) ($MN)
  • Table 90 South America Gene Editing Market Outlook, By Zinc Finger Nuclease (ZFN) (2021-2030) ($MN)
  • Table 91 South America Gene Editing Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 92 South America Gene Editing Market Outlook, By Application (2021-2030) ($MN)
  • Table 93 South America Gene Editing Market Outlook, By Genetic Engineering (2021-2030) ($MN)
  • Table 94 South America Gene Editing Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
  • Table 95 South America Gene Editing Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
  • Table 96 South America Gene Editing Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 97 South America Gene Editing Market Outlook, By End User (2021-2030) ($MN)
  • Table 98 South America Gene Editing Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 99 South America Gene Editing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 100 South America Gene Editing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 101 Middle East & Africa Gene Editing Market Outlook, By Country (2021-2030) ($MN)
  • Table 102 Middle East & Africa Gene Editing Market Outlook, By Product (2021-2030) ($MN)
  • Table 103 Middle East & Africa Gene Editing Market Outlook, By Software & Systems (2021-2030) ($MN)
  • Table 104 Middle East & Africa Gene Editing Market Outlook, By Services (2021-2030) ($MN)
  • Table 105 Middle East & Africa Gene Editing Market Outlook, By Reagents & Consumables (2021-2030) ($MN)
  • Table 106 Middle East & Africa Gene Editing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 107 Middle East & Africa Gene Editing Market Outlook, By Transcription Activator-Like Effector Nuclease (2021-2030) ($MN)
  • Table 108 Middle East & Africa Gene Editing Market Outlook, By Antisense (2021-2030) ($MN)
  • Table 109 Middle East & Africa Gene Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) (2021-2030) ($MN)
  • Table 110 Middle East & Africa Gene Editing Market Outlook, By Zinc Finger Nuclease (ZFN) (2021-2030) ($MN)
  • Table 111 Middle East & Africa Gene Editing Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 112 Middle East & Africa Gene Editing Market Outlook, By Application (2021-2030) ($MN)
  • Table 113 Middle East & Africa Gene Editing Market Outlook, By Genetic Engineering (2021-2030) ($MN)
  • Table 114 Middle East & Africa Gene Editing Market Outlook, By Cell Line Engineering (2021-2030) ($MN)
  • Table 115 Middle East & Africa Gene Editing Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
  • Table 116 Middle East & Africa Gene Editing Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 117 Middle East & Africa Gene Editing Market Outlook, By End User (2021-2030) ($MN)
  • Table 118 Middle East & Africa Gene Editing Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 119 Middle East & Africa Gene Editing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 120 Middle East & Africa Gene Editing Market Outlook, By Other End Users (2021-2030) ($MN)